Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Share-based Compensation: 2020-2025

Historic Share-based Compensation for Beauty Health (SKIN) over the last 5 years, with Sep 2025 value amounting to $2.5 million.

  • Beauty Health's Share-based Compensation fell 68.17% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year decrease of 26.03%. This contributed to the annual value of $26.7 million for FY2024, which is 18.42% up from last year.
  • Per Beauty Health's latest filing, its Share-based Compensation stood at $2.5 million for Q3 2025, which was down 53.75% from $5.3 million recorded in Q2 2025.
  • Beauty Health's Share-based Compensation's 5-year high stood at $8.5 million during Q2 2023, with a 5-year trough of $34,000 in Q1 2021.
  • For the 3-year period, Beauty Health's Share-based Compensation averaged around $5.5 million, with its median value being $5.8 million (2024).
  • In the last 5 years, Beauty Health's Share-based Compensation surged by 20,632.35% in 2022 and then tumbled by 70.36% in 2023.
  • Beauty Health's Share-based Compensation (Quarterly) stood at $3.8 million in 2021, then surged by 100.82% to $7.6 million in 2022, then crashed by 70.36% to $2.3 million in 2023, then soared by 159.08% to $5.8 million in 2024, then tumbled by 68.17% to $2.5 million in 2025.
  • Its Share-based Compensation was $2.5 million in Q3 2025, compared to $5.3 million in Q2 2025 and $3.5 million in Q1 2025.